SIRT5 and breast carcinoma: Despite the negative regulation of glycolysis by SIRT6, SIRT3 and SIRT5 were found to contribute to cancer cell proliferation and survival in diffuse large B cell lymphoma and breast cancer by regulating the function of metabolic enzymes [86,87].